Grasim Industries received a BUY recommendation from ICICI Securities, albeit with a moderated target price of Rs 3,303 from Rs 3,480, reflecting conservative adjustments in the valuations of key h
Motilal Oswal Financial Services has reiterated its BUY recommendation for Sun Pharma, assigning a 12-month target price of Rs 1,960, with the stock currently trading at Rs 1,690.